XDH and chronic kidney disease: Although, over the last several years, some clinical intervention trials including randomized controlled trials (RCTs) have further supported this mechanistic role of UA [72–78], clinical evidence demonstrating the beneficial effect of UA lowering therapy with XO inhibitors on renoprotection and prevention of CKD progression is not certain yet and cannot be easily generalized.